Bruno Bergmans

2.1k total citations
28 papers, 934 citations indexed

About

Bruno Bergmans is a scholar working on Neurology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Bruno Bergmans has authored 28 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 5 papers in Cognitive Neuroscience and 4 papers in Psychiatry and Mental health. Recurrent topics in Bruno Bergmans's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (9 papers) and Alzheimer's disease research and treatments (3 papers). Bruno Bergmans is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (9 papers) and Alzheimer's disease research and treatments (3 papers). Bruno Bergmans collaborates with scholars based in Belgium, United Kingdom and Germany. Bruno Bergmans's co-authors include Bart De Strooper, Katrien Horré, Aikaterini S. Papadopoulou, André Delacourte, Sébastien S. Hébert, Alice Nieuwboer, Rik Vandenberghe, Rose Bruffaerts, Bouwien Smits‐Engelsman and Jolien Schaeverbeke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Brain.

In The Last Decade

Bruno Bergmans

25 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Bergmans Belgium 13 453 257 237 188 119 28 934
Anna Antonell Spain 19 449 1.0× 174 0.7× 540 2.3× 231 1.2× 386 3.2× 40 1.2k
Elena Milanesi Romania 18 430 0.9× 234 0.9× 173 0.7× 41 0.2× 128 1.1× 60 1.1k
Manel Fernández Spain 19 380 0.8× 149 0.6× 343 1.4× 721 3.8× 83 0.7× 40 1.1k
Tomoyasu Bunai Japan 15 303 0.7× 68 0.3× 184 0.8× 79 0.4× 94 0.8× 31 813
Mei Yu China 23 445 1.0× 123 0.5× 136 0.6× 268 1.4× 42 0.4× 39 1.2k
Shahar Barbash Israel 14 711 1.6× 393 1.5× 257 1.1× 61 0.3× 29 0.2× 26 1.1k
Francesca Puca Italy 13 299 0.7× 172 0.7× 238 1.0× 44 0.2× 190 1.6× 24 947
José V. Sánchez‐Mut Spain 17 1.1k 2.5× 123 0.5× 262 1.1× 205 1.1× 83 0.7× 25 1.6k
Luisa P. Cacheaux United States 9 510 1.1× 171 0.7× 114 0.5× 102 0.5× 315 2.6× 12 1.2k
Humberto Arboleda Colombia 20 526 1.2× 49 0.2× 255 1.1× 99 0.5× 122 1.0× 49 1.1k

Countries citing papers authored by Bruno Bergmans

Since Specialization
Citations

This map shows the geographic impact of Bruno Bergmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Bergmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Bergmans more than expected).

Fields of papers citing papers by Bruno Bergmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Bergmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Bergmans. The network helps show where Bruno Bergmans may publish in the future.

Co-authorship network of co-authors of Bruno Bergmans

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Bergmans. A scholar is included among the top collaborators of Bruno Bergmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Bergmans. Bruno Bergmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Malaty, Irene A., Robert A. Hauser, Bruno Bergmans, et al.. (2025). Correlation between sleep and quality of life in people with Parkinson’s disease treated with continuous subcutaneous infusion of foslevodopa/foscarbidopa. Parkinsonism & Related Disorders. 134. 107599–107599. 1 indexed citations
3.
Antonini, Angelo, Bruno Bergmans, Drew S. Kern, et al.. (2025). Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson’s Disease: Post Hoc Analysis of a Randomized Trial. Neurology and Therapy. 15(1). 309–324.
4.
5.
Chaudhuri, К. Ray, Maurizio Facheris, Bruno Bergmans, et al.. (2024). Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa. Movement Disorders Clinical Practice. 11(7). 861–866. 8 indexed citations
6.
Bergmans, Bruno, et al.. (2023). Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 9. 100223–100223. 4 indexed citations
7.
8.
Respondek, Gesine, et al.. (2022). The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers. Neurology and Therapy. 12(1). 229–247. 5 indexed citations
9.
Stocchi, Fabrizio, Angelo Antonini, Daniela Berg, et al.. (2022). Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus. npj Parkinson s Disease. 8(1). 17–17. 16 indexed citations
10.
Matthys, Christophe, Jarissa Maselyne, Christof Van Poucke, et al.. (2021). Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation. npj Parkinson s Disease. 7(1). 72–72. 31 indexed citations
11.
Dijkstra, Bauke W., Moran Gilat, L. Eduardo Cofré Lizama, et al.. (2021). Impaired Weight-Shift Amplitude in People with Parkinson’s Disease with Freezing of Gait. Journal of Parkinson s Disease. 11(3). 1367–1380. 11 indexed citations
12.
Engelborghs, Sebastiaan, Rik Vandenberghe, Rita Cacace, et al.. (2020). Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer’s disease. Neurobiology of Aging. 99. 100.e17–100.e23. 8 indexed citations
13.
Abbruzzese, Giovanni, Jaime Kulisevsky, Bruno Bergmans, et al.. (2020). A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial1. Journal of Parkinson s Disease. 11(1). 187–198. 32 indexed citations
14.
Kuiper, Anouk, Anna L. Bartels, Sterre van der Veen, et al.. (2019). Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes. Parkinsonism & Related Disorders. 69. 85–90. 23 indexed citations
15.
Bruffaerts, Rose, Jolien Schaeverbeke, Natalie Nelissen, et al.. (2019). Multivariate analysis reveals anatomical correlates of naming errors in primary progressive aphasia. Neurobiology of Aging. 88. 71–82. 25 indexed citations
16.
Nackaerts, Evelien, Elke Heremans, Bouwien Smits‐Engelsman, et al.. (2017). Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson’s disease. PLoS ONE. 12(3). e0173157–e0173157. 15 indexed citations
17.
Grube, Manon, Rose Bruffaerts, Jolien Schaeverbeke, et al.. (2016). Core auditory processing deficits in primary progressive aphasia. Brain. 139(6). 1817–1829. 47 indexed citations
18.
Bergmans, Bruno & Bart De Strooper. (2010). γ-secretases: from cell biology to therapeutic strategies. The Lancet Neurology. 9(2). 215–226. 131 indexed citations
19.
20.
Hébert, Sébastien S., Katrien Horré, Bruno Bergmans, et al.. (2008). MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiology of Disease. 33(3). 422–428. 354 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Antonell Breakdown of academic impact, for papers by Elena Milanesi Breakdown of academic impact, for papers by Manel Fernández Breakdown of academic impact, for papers by Tomoyasu Bunai Breakdown of academic impact, for papers by Mei Yu Breakdown of academic impact, for papers by Shahar Barbash Breakdown of academic impact, for papers by Francesca Puca Breakdown of academic impact, for papers by José V. Sánchez‐Mut Breakdown of academic impact, for papers by Luisa P. Cacheaux Breakdown of academic impact, for papers by Humberto Arboleda
Rankless by CCL
2026